Copyright
©The Author(s) 2022.
World J Meta-Anal. Aug 28, 2022; 10(4): 220-237
Published online Aug 28, 2022. doi: 10.13105/wjma.v10.i4.220
Published online Aug 28, 2022. doi: 10.13105/wjma.v10.i4.220
Table 3 Summary of the comparison of median and mean overall survival rates between microwave ablation versus radiofrequency ablation for intrahepatic hepatocellular carcinoma lesions in both cohort studies and randomised controlled trials
Year | MWA sample size | RFA sample size | Median OS | P value | |
MWA | RFA | ||||
1 | 1135 | 1623 | 96.2% | 95.4% | 0.31 |
2 | 651 | 789 | 90.7% | 88.0% | 0.10 |
3 | 1004 | 1480 | 80.5% | 75.3% | 0.002 |
4 | 421 | 464 | 76.8% | 70.0% | 0.02 |
5 | 764 | 1221 | 67.3% | 69.5% | 0.30 |
- Citation: Tang MJ, Eslick GD, Lubel JS, Majeed A, Majumdar A, Kemp W, Roberts SK. Outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma: A systematic review and meta-analysis. World J Meta-Anal 2022; 10(4): 220-237
- URL: https://www.wjgnet.com/2308-3840/full/v10/i4/220.htm
- DOI: https://dx.doi.org/10.13105/wjma.v10.i4.220